SMS Pharmaceuticals Quarterly Results for Trading Insights
SMSPHARMA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹25 Cr
QSept 2025
SMS Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹244 Cr in Sept 2025 (-2.4% vs Mar 2025, +23.2% vs Sept 2024)
- Net Profit of ₹25 Cr in Sept 2025 (+25.0% vs Mar 2025, +78.6% vs Sept 2024)
- EBITDA of ₹50 Cr in Sept 2025 (+19.0% vs Mar 2025)
- Operating Margin of 20.0% in Sept 2025 (+4.0pp vs Mar 2025)
- Earnings Per Share of ₹2.84 in Sept 2025 (+18.3% vs Mar 2025)
SMS Pharmaceuticals Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 244 | 250 | 197 | 198 | 248 | -2.4% | 23.2% |
| Net Profit (₹ Cr) | 25 | 20 | 21 | 14 | 17 | - | - |
| EBITDA (₹ Cr) | 50 | 42 | 40 | 33 | 35 | - | - |
| EPS (₹) | 2.84 | 2.40 | 2.31 | 1.67 | 2.04 | - | - |
| Operating Margin (%) | 20.0% | 16.0% | 20.0% | 16.0% | 14.0% | - | - |
SMS Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize SMS Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in SMS Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for SMS Pharmaceuticals
Additional stock information and data for SMSPHARMA
Revenue Trend (₹ Cr)
Sept 2024
198
Jun 2025
197
Mar 2025
250
Sept 2025
244
Net Profit Trend (₹ Cr)
Sept 2024
14
Jun 2025
21
Mar 2025
20
Sept 2025
25
Operating Margin Trend (%)
Sept 2024
16.0%
Jun 2025
20.0%
Mar 2025
16.0%
Sept 2025
20.0%
Sector Competitors - Quarterly Performance Comparison
Comparing SMS Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores